Lubrizol’s Apinovex polymer received the prestigious Celebration Award in the Pharma Excipients category at CPhI China, held in Shanghai from June 24–26.

Apinovex polymer’s recognition places it alongside Lubrizol’s other innovative excipient, Apisolex polymer, which has earned multiple honors. These accolades highlight Lubrizol’s ongoing commitment to advancing next-generation excipient technologies that enhance drug delivery by improving the solubility and bioavailability of APIs.

“We are thrilled to receive this additional recognition from CPhI, following the earlier innovation awards for our novel injectable excipient, Apisolex polymer,” said Matt Finkelhor, Global Commercial Manager, Novel Polymers at Lubrizol. “These awards reaffirm that Lubrizol’s innovations are making a meaningful impact in drug delivery—enhancing bioavailability and helping bring more life-changing therapies to market.”